Abstract
Proteostasis alteration and neuroinflammation are typical features of normal aging. We have previously shown that neuroinflammation alters cellular proteostasis through immunoproteasome induction, leading to a transient decrease of proteasome activity. Here, we further investigated the role of acute lipopolysaccharide (LPS)-induced hippocampal neuroinflammation in cellular proteostasis. In particular, we focused on macroautophagy (hereinafter called autophagy) and endoplasmic reticulum-associated protein degradation (ERAD). We demonstrate that LPS injection induced autophagy activation that was dependent, at least in part, on glycogen synthase kinase (GSK)-3β activity but independent of mammalian target of rapamycin (mTOR) inhibition. Neuroinflammation also produced endoplasmic reticulum (ER) stress leading to canonical unfolded protein response (UPR) activation with a rapid activating transcription factor (ATF) 6α attenuation that resulted in a time-dependent down-regulation of ERAD markers. In this regard, the time-dependent accumulation of unspliced X-box binding protein (XBP) 1, likely because of decreased inositol-requiring enzyme (IRE) 1α-mediated splicing activity, might underlie in vivo ATF6α attenuation. Importantly, lactacystin-induced activation of ERAD was abolished in both the acute neuroinflammation model and in aged rats. Therefore, we provide a cellular pathway through which neuroinflammation might sensitize cells to neurodegeneration under stress situations, being relevant in normal aging and other disorders where neuroinflammation is a characteristic feature.
Similar content being viewed by others
Introduction
Neuroinflammation and proteostasis disruption are characteristics of normal aging and some age-related neurodegenerative diseases. Cellular proteostasis is mainly sustained by the ubiquitin proteasome system and autophagy, which could act coordinately under specific situations1. A consequence of proteostasis alteration is ER-stress. Under this situation, cells activate the UPR, which is mediated by IRE1α, ATF6α and double-stranded RNA-dependent protein kinase-like endoplasmic reticulum kinase (PERK) signalling pathways2. An efficient UPR activation is necessary for a proper response to cellular challenges in order to resolve stress situations and preserve cell viability. However, others and we have demonstrated that proper UPR activation is disrupted in aged animals leading to neurodegeneration3,4,5,6,7,8, despite the causes of this effect are not well known.
On the other hand, low-grade chronic inflammation is also a marker for aging9,10,11,12 and represents a factor rising up cell vulnerability to proteasomal stress13. Importantly, neuroinflammation, autophagy and UPR are three interrelated processes, which can influence each other depending on different factors and stressors14, 15. In this regard, in vitro experiments revealed that LPS treatment induced autophagy cell death in an UPR dependent manner16. However, autophagy can be also activated by other mechanisms including m-TOR inhibition or both GSK-3β inhibition or activation depending on the cell type or stressors. Moreover, modulation of the inflammatory response and cytokine production is dependent on toll-like receptor (TLR) activation of XBP1 in both macrophages17 and rheumatoid arthritis synoviocytes18, and also on the cross-talk between GSK-3β and XBP119. In consequence, a better comprehension of the in vivo relationships between neuroinflammation, UPR and autophagy would be useful for understanding how the neuroinflammatory response could be modulated in the context of aging or neurodegenerative diseases. Therefore, we set out to investigate the role of LPS-induced neuroinflammation on UPR and autophagy in rat hippocampus. Our results indicate that LPS injection activated both autophagy and UPR. Autophagy activation was depended, at least in part, on GSK-3β activity but independent of mTOR inhibition. On the other hand, LPS injection produced a canonical but short UPR activation. Both ATF6α and IRE-1α were quickly attenuated, leading to down-regulation of ERAD markers. Importantly, the up-regulation of ERAD markers induced by proteasome inhibition was abolished in both aged rats and LPS-injected young animals. These results suggest that neuroinflammation-induced ERAD inactivation might increase cell vulnerability under proteasomal stress situations.
Results
LPS injection induces autophagy activation in rat hippocampus
We have previously demonstrated that LPS-induced neuroinflammation in rat hippocampus led to immunoproteasome induction and transient decrease of proteasome activity13. Therefore, we analyzed whether LPS injection could activate autophagy in order to sustain proteolytic activity. As shown, LPS injection induced a rapid and significant increase of some autophagic markers such as light chain 3 (LC3)-II (Fig. 1A) and Atg7 (Fig. 1B,C and Supplementary Fig. S1A). Also, LPS injection triggered specific transcriptional up-regulation of the BCL2 associated athanogene 3 (bag3), but not bag1, which are involved in delivering proteins for degradation to the autophagy or the proteasome, respectively (Supplementary Fig. S1B and C)20. Moreover, the amount of p62 protein, which is considered a marker for autophagic flux, showed a time-dependent decrease, but without statistical significance (Fig. 1B and D). The LPS-dependent increase in autophagic flux was also supported by in vitro experiments (Supplementary Fig. S1D). On the other hand, the master transcription factor EB (TFEB), which coordinates both autophagy and lysosomal biogenesis, was significantly increased after LPS injection (Fig. 1B and E) and the expression of the lysosomal marker cathepsin D decreased significantly from 6 to 14 hours, supporting lysosomal degradation of autophagosomes (Fig. 1F). Taken together, these data indicate that LPS injection activates autophagy in rat hippocampus. Importantly, the timeframe of autophagy activation was coincident with the replacement of constitutive proteasomes by the immunoproteasomes (Supplementary Fig. S2).
LPS-induced autophagy is partially dependent on GSK-3β activity but independent on mTOR inhibition
Next, we searched for the cellular pathways that might be involved in LPS-induced autophagy activation. Based on previous data we first focused on the Akt/GSK-3β/βcatenin axis1, 21. As shown, LPS injection induced early Akt activation as indicated the higher amount of both phosphoSer473Akt (Fig. 2A upper panel and 2B) and phosphoThr308Akt (data not shown) from 3 to 6 hours. Despite Akt activation, the amount of phosphoSer9-GSK-3β, a target protein of Akt, was significantly reduced during this time, supporting that LPS injection increased basal activity of GSK-3β (Fig. 2A middle panel and 2C). This was confirmed by the significant decrease of β-catenin (Fig. 2A lower panel). We next tested whether GSK-3β activity could be involved in LPS-induced autophagy activation. For that purpose, we performed a new set of experiments using LPS-treated N13 cells in the presence of the GSK-3β inhibitor VII. Similarly as observed in vivo, LPS treatment increased the LC3-II/LC3-I ratio. However, it was partially reversed in the presence of the GSK-3β inhibitor VII (Supplementary Fig. S3). These data indicate that LPS-induced autophagy activation is partially dependent on GSK-3β activity.
Because mTOR inhibition is involved in autophagy activation22, we also investigated the Akt/mTOR/S6K pathway. As shown in Fig. 2D and E, phosphorylated mTOR at Ser2448 was significantly increased from 3 to 6 hours but decreased at 14 and 24 hours, indicating that mTOR was activated from 3 to 6 hours. This was corroborated by increased phosphorylation of the target proteint of mTOR p70 ribosomal S6 kinase (Fig. 2D lower panel). Taken together, these results show the LPS injection activates both Akt/GSK-3β/βcatenin and Akt/mTOR/S6K pathways, being autophagy activation partially dependent on GSK-3β activity but independent on mTOR inhibition.
LPS injection induces UPR activation
We next wondered if LPS-induced proteostasis alteration could affect the ER homeostasis. Thus, we searched for ER-stress by evaluating UPR activation. To address this issue, we carried out a detailed molecular analysis of specific markers of the three arms of the UPR.
IRE1α pathway
As shown in Fig. 3A, LPS injection produced mRNA up-regulation of the Xbp1 gene and the phosphorylation of IRE1α (Fig. 3B), indicating that the IRE1α pathway was early activated after LPS injection. The Xbp1 mRNA is spliced by the nuclease activity of the phospho-IRE1α, leading after translation, to the active transcription factor XBP1 (sXBP1). In this regard, the amount of sXBP1 increased significantly in the nuclear fractions at 3 hours, decreasing afterwards in a time-dependent manner (Fig. 3C and D). By contrast, the unspliced XBP1 protein (usXBP1), which is produced by translation of the Xbp1 mRNA (not spliced), increased in an opposite manner (Fig. 3C). This resulted in a time-dependent switch in the sXBP1/usXBP1 protein ratio (Fig. 3E). Because IRE1α activation was observed for no longer than 3 hours, we further investigated whether the time-dependent reduction in the sXBP1 protein could be explained by a reduction in the amount of spliced Xbp1 mRNA. In this regard, data demonstrated a time-dependent and significant decrease in the content of spliced Xbp1 mRNA that paralleled the sXBP1protein decrease (Fig. 3F).
On the other hand, the IRE1α arm activates the c-Jun N-terminal kinase (JNK) pathway through the formation of an IRE1α-TRAF2-ASK1 complex. As shown in Fig. 3G–H, LPS injection decreased phosphorylation of both JNK isoforms at 6 hours, supporting JNK inactivation. However, from 6 to 24 hours the phospho-JNK-2/JNK-2 ratio remained low, whereas the phospho-JNK-1/JNK-1 ratio was significantly increased, suggesting that LPS-induced neuroinflammation might affect differentially both JNK isoforms.
ATF6α pathway
LPS injection also activated the ATF6α arm. While the full-length ATF6α (flATF6α) protein seemed not to be altered by LPS injection, its processing was activated leading to a significant increase of the processed ATF6α (pATF6α) protein in the cytosolic fractions, 3 hours after LPS injection (Fig. 4A and B), and later (6 hours) in the nuclear fractions (Fig. 4C). Accordingly, glucose regulated protein 78 (Grp78), which is mostly under the control of pATF6α23 increased from 6 to 14 hours (Fig. 4D and E). Importantly, the ATF6α pathway was briefly activated as revealed by the absence of pATF6α in the nuclear fractions beyond 6 hours, and the fact that it was almost depleted from 14 to 24 hours from the cytosolic fractions (Fig. 4A).
PERK pathway
As shown in Fig. 5A, LPS injection significantly increased the phospho-eukaryotic initiation factor 2α (peIF2α)/eIF2α ratio and the amount of the PERK-related transcription factor ATF4 from 6 to 24 hours (Fig. 5B), indicating PERK activation. However, the presence of ATF4 in the nuclear fractions was evident from 3 to 6 hours, suggesting that LPS-induced nuclear translocation of ATF4 might occur in a PERK-independent manner. Indeed, transcriptional induction of the transcription factor C/EBP homologous protein (CHOP), which is under the control of ATF4, was significantly upregulated 3 hours after LPS injection. However, CHOP protein was not observed at any time (data not shown).
All in all, these data support that LPS injection alters hippocampal ER homeostasis leading to full UPR activation. Moreover, the three pathways showed different time courses of activation/deactivation being the ATF6α the later activated but the earliest attenuated.
LPS injection down-regulates ERAD markers expression
ERAD markers are under the control of both pATF6α and sXBP123. To investigate whether nuclear depletion of both pATF6α and sXBP1 could have functional relevance, we evaluated ERAD activation by analysing the expression of several ERAD-associated molecules involved in both recognition and retrotranslocation of misfolded and/or unfolded proteins. Interestingly, despite LPS injection produced UPR activation none of the ERAD markers analyzed was transcriptionally up-regulated. By contrast, the mRNA expression of ERAD markers tended to decrease in time-dependent manner, being all of them significant at 24 hours (Fig. 6A). Importantly, protein analysis also revealed a significant reduction in the amount of some ERAD proteins (Fig. 6B). Taken together, these data demonstrate that LPS injection inactivated ERAD by down-regulating ERAD markers, likely as consequence of the nuclear depletion of both transcription factors pATF6α and sXBP1.
LPS injection attenuates lactacystin-induced up-regulation of ERAD markers
ERAD activity should be adapted in response to different stressors such as proteasome inhibition to restore proteostasis. Therefore, we tested whether LPS-induced ERAD inactivation could affect ERAD activation induced by proteasomal stress. To address this issue we analyzed the expression of ERAD markers in rats subjected to proteasome inhibition alone (SAL+LT group), and in rats injected with LPS 24 hours before proteasome inhibition (LPS+LT group). In both groups, ERAD expression was analyzed 24 hours after LT injection. As expected, LT injection activated ERAD as revealed by the significant mRNA up-regulation of derlin1, derlin2 and valosin containing protein (vcp)/97 (Fig. 7A). However, when proteasome was inhibited 24 hours after LPS injection (LPS+LT), LT-induced upregulation was significantly reduced when compared with LT-injected animals (SAL+LT). Therefore, this data suggests that neuroinflammation could affect ERAD activation under proteasome stress. To test this possibility in a more physiological situation, we induced proteasome inhibition in aged rats, which develop low-grade chronic neuroinflammation9, 12, 24, and we analyzed ERAD markers. Importantly, basal expression of ERAD markers was significantly increased in aged rats, suggesting a higher basal ER-stress (Supplementary Fig. S4), and differences between acute versus chronic neuroinflammation. However, and contrary to young rats, lactacystin injection just up-regulated the mRNA expression of vcp/97 in aged animals, while the other markers remained similar to saline-injected rats (Fig. 7B). These differences were also evident at the protein level as revealed the significant increase of Derlin 1 in young, but no in aged, LT-treated rats (Fig. 7C). These findings strongly support that age-related neuroinflammation might be a relevant factor contributing to defective ERAD activation under proteasome stress.
Discussion
Here, we provide solid evidence showing that neuroinflammation alters hippocampal proteostasis at different levels. Our findings demonstrate that LPS-induced neuroinflammation produced: (i) autophagy activation; (ii) UPR activation; (iii) ERAD down-regulation; and (iv) ERAD inactivation under proteasomal stress.
It is well established that in both aged hippocampus and neuroinflammation models, the constitutive proteasomes are replaced by the immunoproteasomes9, 13, 25,26,27. We had previously demonstrated that LPS injection induced proteasome to immunoproteasome exchange that is accompanied by a transient reduction of proteasomal proteolytic activity13. Here, we show that LPS-induced neuroinflammation activated autophagy at the same time constitutive proteasomes were replaced by the immunoproteasomes. The expression of several macroautophagy-related markers such as LC3-II, Atg7, bag3 and p62 was altered by LPS injection. Moreover, the master transcription factor TFEB that coordinates autophagy activation and lysosomal biogenesis, increased after LPS injection, and the level of both pro-cathepsin and active cathepsin D were altered. In consequence, we propose that during neuroinflammation, autophagy might be acting as a compensatory mechanism in order to cope with the transient loss of proteolytic activity due to the proteasome to immunoproteasome exchange. These findings reinforce the idea that insufficient proteasomal activity, whatever the reasons, could activate autophagy, and support the functional cooperation between both proteolytic systems1, 28,29,30.
Autophagy is a catabolic process that can be activated in response to a multitude of stimuli through different cellular pathways22, 31, 32. In this regard, our data indicated that autophagy activation seemed to be dependent, at least in part, on GSK-3β activity. Interestingly, GSK-3β activity has also been shown to increase autophagic flux in adult hippocampal neural stem cells after insulin withdrawal33 and increased GSK-3β activity during ER-stress has been described in the context of neuroinflammation19. However, we cannot discard other factors, in addition to GSK-3β activity, that could contribute to LPS-induced autophagy activation. ER-stress markers such as Grp78 up-regulation, sXBP1depletion, PERK/eIF2α phosphorylation or ATF4 stabilization, all of them observed in this study, have been shown to participate in the UPR-induced autophagy activation30, 34, 35. Taken toghether, all these data indicate that activation of the axis ER-stress-GSK-3β-autophagy might be relevant during neroinflammation. Surprisingly, we also observed activation of the Akt/mTOR/S6K pathway, a situation that could be compatible with autophagy inhibition36. In this case, Akt/mTOR/S6K activation would be modulating excessive autophagy through mTOR activation in order to limit cell death during neuroinflammation as previously suggested22. In global, neuroinflammation could modulate autophagy by inducing two opposite pathways in order to get a precise control on autophagy activity. LPS injection also produced a full but faint UPR activation, supporting that neuroinflammation induces ER-stress. Importantly, ER-stress and UPR are related to the induction of proinflammatory cytokines. In particular, XBP1 is activated by TLR2 and TLR4 receptors in macrophages17 and it is involved in TNFα production and regulation of innate immune response17, 19. In consequence, LPS injection might activate the IRE-1α-XBP1 axis through TLR4 receptor to stimulate TNFα production. In this regard, expression of TNFα, but not of IL-1β or iNOS, took place from 3 to 6 hours after LPS injection13. However, we also observed a weak and short activation of both ATF6α and IRE1α pathways. Interestingly, LPS injection gave rise to a time-dependent accumulation of the usXBP1 protein, which inversely correlated with both decreased sXBP1 and pATF6α depletion from the nuclear fractions. In particular, pATF6α was not longer detected in the nuclear fractions beyond 6 hours and was completely depleted from the cytosolic fractions from 14 to 24 hours, when usXBP1 protein levels were maximal. The cellular content of usXBP1 is tightly regulated37 and it has been shown to interact with both sXBP1 and pATF6α, but not with ATF438, 39, sequestering them from the nucleus and increasing proteasomal-dependent degradation of these complexes37. All these data strongly suggest the interesting possibility that under in vivo neuroinflammation, usXBP1 might be modulating the duration and/or intensity of the UPR. In fact, we did not observe activation of ERAD, but rather its inactivation by down-regulation of ERAD-associated molecules, nor CHOP expression17. An important issue will be to understand the reasons leading to usXBP1 accumulation in the setting of neuroinflammation. In this regard, we demonstrated that LPS injection produced both a reduction in the amount of sXbp1 mRNA, which support a lower IRE1α-mediated RNAase activity, and GSK-3β activation, two effects that seem to be causally related since GSK-3β activation inhibits the endonuclease activity of IRE-1α19. Thus, it is tempting to speculate that LPS-induced activation of GSK-3β might be involved, somehow, in the inhibition of IRE1α-mediated RNAase activity. However, we cannot discard that other factors such as S-nitrosylation might be affecting the IRE1α-mediated RNAase activity in the context of neuroinflammation40, 41.
Present data might be relevant in the context of normal aging for which low-grade chronic neuroinflammation is a hallmark9. In this regard, we have previously shown that proteasome inhibition in aged rat hippocampus produced: (i) weak activation and rapid attenuation of both IRE-1α and ATF6α; (ii) usXBP1 accumulation; (iii) GSK-3β activation; and (iv) neurodegeneration1, 7. Moreover, here we have demonstrated that ERAD was not properly activated following proteasome inhibition in aged rats. Importantly, all of these age-related alterations were reproduced in young LPS-injected rats, pointing out to neuroinflammation as a negative element disturbing cellular proteostasis and increasing neurodegeneration13.
In conclusion, a better understanding of how UPR activation is afected in the context of inflammation could have a crucial role in the comprehension of some diseases such as bowel diseases, neurodegenerative diseases or even aging and might help in developing relevant therapeutic tools for treating theses diseases or, at least, alleviating their symptoms.
Methods
Animals
Young (3–4 months old) and aged (24–26 months old) male Wistar rats were provided by the animal care facility of the University of Seville. Animals were maintained at 22 to 24 °C and had free access to food and water. All experiments were approved by the ethical committee of the University of Seville and complied with international animal welfare guidelines.
Surgery
Young rats (n = 28) and aged rats (n = 3) were processed for surgery and drug injection exactly as previously described13. Different groups of animals were established. i) Young rats injected with LPS (Sigma-Aldrich, St Louis MO, USA). LPS was dissolved (5 mg/ml) in a solution of sterilized PBS and 1 μl was injected into both hippocampi. The rats were anesthetized with 400 mg/kg chloral hydrate and positioned in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA). According to Paxinos’ atlas the coordinates were: 3.3 mm posterior, 1.6 mm lateral and 3.2 mm ventral to the bregma and 4.8 mm posterior, 5.5 mm lateral and 6.0 mm ventral to the bregma. The injections were delivered over a period of 2 min, and after each, the needle was left in situ for an additional 5 min to avoid reflux along the injection track. After deep anesthesia with sodium pentobarbital animals were sacrificed at 3, 6, 14 and 24 hours after LPS injection and brains were quickly removed. Control animals were processed in a similar way but received 1 μl of sterilized PBS in both hippocampi. ii) Young rats injected with saline + lactacystin (LT) or LPS + lactacystin (LPS+LT). In this case, LT (Sigma-Aldrich, St Louis MO, USA) was dissolved (5 mg/ml) in a solution of sterilized PBS and 1 μl was injected into both hippocampi. For each case, saline or LPS was first administered and 24 hours later, LT was injected through the same drilled hole. Finally, after deep anesthesia with sodium pentobarbital animals were sacrificed 24 hours after the last injection. iii) Aged rats injected with LT. Aged rats were processed similarly as LPS injected rats but the coordinates were: 6.0 mm posterior, ±4.6 mm lateral and 4.6 mm ventral to the bregma as previously shown7. After deep anesthesia with sodium pentobarbital, animals were sacrificed 24 hours after LT injection. For all cases both hippocampi were dissected, frozen in liquid N2, and stored at −80 °C until use.
Sample preparation
Hippocampi were homogenized in 700 μL of ice-cold sucrose buffer (0.25 M sucrose, 1 mM EDTA, 10 mM Tris-HCl, pH 7.4), supplemented with a protease inhibitor cocktail (Sigma-Aldrich, St Louis MO, USA). Three hundred μL were separated and subsequently used for RNA isolation (see below). The remaining homogenate (400 μL) was stored at −80 °C until use.
Subcellular fractionation
The nuclear and the cytosolic fractions were obtained from the 400 μL homogenate by sequential centrifugation steps as previously described27. The homogenized sample was first cleaned by centrifugation at 500 g for 10 min, and the supernatant recentrifuged at 600 g for 10 min. Then, the supernatant was further centrifuged at 3000 g for 10 min and the pellet was re-suspended in 300 μL of sucrose buffer with protease inhibitors and centrifuged at 3000 g for 10 min. This step was repeated twice. The final pellet, considered as the nuclear fraction, was resuspended in sucrose buffer with protease inhibitors and stored at −80 °C until use. The cytosolic fraction was obtained by centrifugation of the first 3000 g supernatant at 15000 g for 45 min. The resulting supernatant, considered as the cytosolic fraction, was stored at −80 °C until use. The purity of both cellular fractions was tested by western blot using the nuclear protein antibody Lamina. Protein concentration was determined in each fraction by the Lowry method.
Western blotting
Immunoblots were done as previously described1. Briefly, proteins were loaded on a 12 or 14% polyacrylamide gel for electrophoresis (SDS-PAGE; Bio-Rad, Alcobendas, Spain), and then transferred to a nitrocellulose membrane (Hybond-C Extra; Amersham, Barcelona, Spain). After blocking, membranes were incubated overnight at 4 °C with the following primary antibodies: (i) rabbit polyclonal antibodies against: XBP1 (ab37151) at 1 μg/mL; VCP-97 (ab11433) at 1/2000 dilution and lamin B at 1/1000 dilution from Abcam, Cambridge, UK. Grp78 (#SPA-826) at 1/2000 dilution from Stressgen. EDEM2 (E1782) at 1 μg/mL from Sigma-Aldrich, Madrid, Spain. Phospho-S6K (sc-11759) at 1/1000 dilution and ATF6α (sc-22799) at 1⁄1500 dilution from Santa Cruz Biotechnology, USA. LC3B (#2775); Atg7 (#2631); p62 (#5114); phospho-Akt (#9271); Akt (#9272); phospho-GSK-3β (#9336); phospho-JNK (#9251); JNK (#9252); eIF2α (#9722); ATF4 (#11815); Derlin1 (#8897); mTOR (#2972); phospho-mTOR (#2971) at 1/1000 dilution from Cell Signaling, Danvers, MA, USA. TFEB (NB100–93447) at 1/1000 dilution from Novus, Madrid, Spain. (ii) Mouse or rabbit monoclonal antibodies against IRE1α (#3294); OS9 (#12497); Phospho-eIF2α (#3597) at 1⁄1000 dilution from Cell Signaling. GSK-3β (#05-412) at 1⁄1000 dilution from Millipore. β-catenin (ab32572) and phospho-IRE1α (ab124945) at 1⁄1000 dilution from Abcam, Cambridge, UK. Cathepsin D (AF1C7) at 1⁄2000 dilution from AbFrontier Seoul, Korea. β-actin (A 5316) at 1⁄1000 dilution from Sigma-Aldrich, Madrid, Spain. Then, membranes were incubated with the appropriate secondary antibodies horseradish peroxidase-conjugated from Dako, Denmark at a dilution of 1/10000 and developed using the ECL-plus detection method (Amersham, Barcelona, Spain) and the ImageQuant LAS 4000 MINI GOLD (GE Healthcare Life Sciences, Barcelona, Spain). For quantification, the optical density of individual bands was analyzed using PCBAS 2.08 software (Raytest Inc, Berlin, Germany), and normalized relative to the optical density of β-actin or lamin B.
RNA extraction and reverse transcription
For PCR analysis, total RNA was extracted using the Tripure Isolation Reagent (Roche, Mannheim, Germany) according to the instructions of the manufacturer. The recovery of RNA was similar in young and aged rats. Reverse transcription was performed using random hexamers primers exactly as previously described1.
Real-time PCR
PCR was performed in an ABI Prism 7000 sequence detector (Applied Biosystems, Madrid, Spain) using cDNA diluted in sterile water as template. The xbp1, chop, Atf6, grp78, derlin1, derlin2, vcp/p97, edem1, edem2, os9 and the housekeeper genes were amplified using specific Taqman probes supplied by Applied Biosystems, Madrid, Spain. The spliced Xbp1 mRNA was amplified using the following pair of primers (from 5′ to 3′): sXbp1UP: GCTTGTGATTGAGAACCAGG and sXbp1LO: GGCCTGCACCTGCTGCGGACTC7. Threshold cycle (Ct) values were calculated using the software supplied by Applied Biosystems, Madrid, Spain.
Cell culture
Microglial N13 cells were cultured in RPMI 1640 medium (Sigma-Aldrich, Madrid, Spain), supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin (Euroclone, Milano, Italy). Cells were stimulated with 0.5 μg/ml of LPS (L3024 S), from Sigma-Aldrich, Madrid, Spain, for 5 hours in the presence or the absence of 20 μM of the GSK-3β inhibitor VII (361548) from Calbiochem, UK, or 0.5 μg/ml of LPS for 4 hours followed by 1 μM of bafilomycin A1 (CAS 88899-55-2) for 5 more hours. Samples were collected using loading sample buffer and processed for Western blot experiments.
Statistical analysis
Data were expressed as mean ± SD. For comparison between several groups, we used a multifactor ANOVA, followed by Bonferroni post hoc multiple comparisons tests (Statgraphics plus 3.1) (Warrenton, VA, USA). The significance was set at 95% of confidence. Significant differences are referenced as P < 0.05: *respect to saline-injected animals or, #respect to young animals. The comparison between saline and LT injected aged rats was done by two-tailed t test.
References
Gavilán, E. et al. Age-related dysfunctions of the autophagy-lysosomal pathway in hippocampal pyramidal neurons under proteasome stress. Neurobiol Aging. 36, 1953–1963 (2015).
Malhotra, J. D. & Kaufman, R. J. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol. 18, 716–731 (2007).
Paz Gavilán, M. et al. Cellular environment facilitates protein accumulation in aged rat hippocampus. Neurobiol Aging. 27, 973–982 (2006).
Hussain, S. G. & Ramaiah, K. V. Reduced eIF2alpha phosphorylation and increased proapoptotic proteins in aging. Biochem. Biophys. Res. Commun. 355, 365–370 (2007).
Salminen, A. & Kaarniranta, K. ER stress and hormetic regulation of the aging process. Ageing Res Rev. 9, 211–217 (2010).
Naidoo, N., Ferber, M., Master, M., Zhu, Y. & Pack, A. I. Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J Neurosci. 28, 6539–6548 (2008).
Gavilán, M. P. et al. Dysfunction of the unfolded protein response increases neurodegeneration in aged rat hippocampus following proteasome inhibition. Aging Cell 8, 654–665 (2009).
Taylor, R. C. Aging and the UPR(ER). Brain Res. 1648, 588–593 (2016).
Gavilán, M. P. et al. Molecular and cellular characterization of the age-related neuroinflammatory processes occurring in normal rat hippocampus: potential relation with the loss of somatostatin GABAergic neurons. J Neurochem. 103, 984–996 (2007).
Shaw, A. C., Goldstein, D. R. & Montgomery, R. R. Age-dependent dysregulation of innate immunity. Nat. Rev.Immunol. 13, 875–887 (2013).
Deleidi, M., Jäggle, M. & Rubino, G. Immune aging, dysmetabolism, and inflammation in neurological diseases. Front Neurosci. 9, 172 (2015).
Barrientos, R. M., Kitt, M. M., Watkins, L. R. & Maier, S. F. Neuroinflammation in the normal aging hippocampus. Neurosci. 309, 84–99 (2015).
Pintado, C. et al. Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampus. J Neuroinflamm. 9, 87 (2012).
Salminen, A., Kauppinen, A., Suuronen, T., Kaarniranta, K. & Ojala, J. ER stress in Alzheimer’s disease: a novel neuronal trigger for inflammation and Alzheimer’s pathology. J Neuroinflamm. 26, 6:41 (2009).
Su, P. et al. The role of autophagy in modulation of neuroinflammation in microglia. Neuroscience. 319, 155–167 (2016).
Li, S. et al. Lipopolysaccharide Induces Autophagic Cell Death through the PERK-Dependent Branch of the Unfolded Protein Response in Human Alveolar Epithelial A549 Cells. Cell Physiol Biochem. 36, 2403–2417 (2015).
Martinon, F., Chen, X., Lee, A.-H. & Glimcher, L. H. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol. 11, 411–420 (2010).
Savic., S. et al. TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. J Autoimmun. 50, 59–66 (2014).
Kim et al. Endoplasmic reticulum stress-induced IRE1α activation mediates cross-talk of GSK-3β and XBP-1 to regulate inflammatory cytokine production. J Immunol. 194, 4498–4506 (2015).
Gavilán, E., Sánchez-Aguayo, I., Daza, P. & Ruano, D. GSK-3β signaling determines autophagy activation in the breast tumor cell line MCF7 and inclusion formation in the non-tumor cell line MCF10A in response to proteasome inhibition. Cell Death Dis. 4, e572 (2013).
Parr, C. et al. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein. Mol Cell Biol. 32, 4410–4418 (2012).
Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J. & Pedraza-Chaverri, J. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 26, 2694–2701 (2014).
Yamamoto, K. et al. Transcriptional Induction of Mammalian ER Quality Control Proteins Is Mediated by Single or Combined Action of ATF6α and XBP1. Dev. Cell. 13, 365–376 (2007).
Griffin, R. et al. The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem. 99, 1263–1272 (2006).
Seifert, U. et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142, 613–624 (2010).
Nathan, J. A. et al. Immuno- and constitutive proteasomes do not differ in their abilities to degrade ubiquitinated proteins. Cell 152, 1184–1194 (2013).
Gavilán, M. P. et al. Age-related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects. J Neurochem. 108, 260–272 (2009).
Korolchuk, V. I., Menzies, F. M. & Rubinsztein, D. C. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 584, 1393–1398 (2010).
Park, C. & Cuervo, A. M. Selective Autophagy: Talking with the UPS. Cell Biochem Biophys. 67, 3–13 (2013).
Schneider, J. L. et al. Loss of hepatic chaperone-mediated autophagy accelerates proteostasis failure in aging. Aging Cell 14, 249–264 (2015).
Verfaillie, T., Salazar, M., Velasco, G. & Agostinis, P. Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy. Int J Cell Biol. 2010, 930509 (2010).
Cuervo, A. M. & Macian, F. Autophagy, nutrition and immunology. Mol Aspects Med. 33, 2–13 (2012).
Zhai, P., Sciarretta, S., Galeotti, J., Volpe, M. & Sadoshima, J. Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion. Circ Res. 109, 502–511 (2011).
Benbrook, D. M. & Long, A. Integration of autophagy, proteasomal degradation, unfolded protein response and apoptosis. Exp Oncol. 34, 286–297 (2012).
Doyle, K. M. et al. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J Cell Mol Med. 15, 2025–2039 (2011).
Crino, P. B. The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol. 12, 379–392 (2016).
Tirosh, B., Iwakoshi, N. N., Glimcher, L. H. & Ploegh, H. L. Rapid turnover of unspliced Xbp-1 as a factor that modulates the unfolded protein response. J Biol Chem. 281, 5852–5860 (2006).
Yoshida, H., Nadanaka, S., Sato, R. & Mori, K. XBP1 is critical to protect cells from endoplasmic reticulum stress: evidence from Site-2 protease-deficient Chinese hamster ovary cells. Cell Struct Funct. 31, 117–125 (2006).
Yoshida, H., Uemura, A. & Mori, K. pXBP1(U), a negative regulator of the unfolded protein response activator pXBP1(S), targets ATF6 but not ATF4 in proteasome-mediated degradation. Cell Struct Funct. 34, 1–10 (2009).
Yang, L. et al. S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction. Science 349, 500–506 (2015).
Nakato, R. et al. Regulation of the unfolded protein response via S-nitrosylation of sensors of endoplasmic reticulum stress. Sci Rep. 5, 14812 (2015).
Acknowledgements
This work was supported by Fondo de Investigación Sanitaria (FIS), from the Instituto de Salud Carlos III (ISCiii) of Spain, co-financed by ERDF funds from the European Union, through grant PI12/00445 (D.R.). H.D.-M. is supported by a fellowship from the Plan Propio de Investigación of the University of Sevilla. We thanks, Dr. Jose L. Crespo for his kindly supply of the phospho-S6K antibody. Albert G. Quintanilla for english supervision.
Author information
Authors and Affiliations
Contributions
D.R., A.C. and C.P. designed research. A.C. and C.P. performed animal surgery. C.P., S.M. and H.D.-M. performed main research and analyzed data experiments. D.R. supervised research and wrote the paper. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pintado, C., Macías, S., Domínguez-Martín, H. et al. Neuroinflammation alters cellular proteostasis by producing endoplasmic reticulum stress, autophagy activation and disrupting ERAD activation. Sci Rep 7, 8100 (2017). https://doi.org/10.1038/s41598-017-08722-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-08722-3
- Springer Nature Limited
This article is cited by
-
Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
Cell & Bioscience (2021)
-
Celecoxib-Dependent Neuroprotection in a Rat Model of Transient Middle Cerebral Artery Occlusion (tMCAO) Involves Modifications in Unfolded Protein Response (UPR) and Proteasome
Molecular Neurobiology (2021)
-
Proteasomal Inhibition Redirects the PrP-Like Shadoo Protein to the Nucleus
Molecular Neurobiology (2019)
-
SIRT1 activation with neuroheal is neuroprotective but SIRT2 inhibition with AK7 is detrimental for disconnected motoneurons
Cell Death & Disease (2018)